Subcutaneous ivermectin use in the treatment of severeStrongyloides stercoralisinfection: two case reports and a discussion of the literature: Table 1. | Zendy

Jessica Barrett | Zendy; Claire Broderick | Zendy; Hannah M Soulsby | Zendy; Paul Wade | Zendy; William Newsholme | Zendy

Open Access

Subcutaneous ivermectin use in the treatment of severeStrongyloides stercoralisinfection: two case reports and a discussion of the literature: Table 1.

Author(s) -

Jessica Barrett,

Claire Broderick,

Hannah M Soulsby,

Paul Wade,

William Newsholme

Publication year - 2015

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkv315

Subject(s) - strongyloides stercoralis , ivermectin , strongyloidiasis , medicine , immunology , helminths , veterinary medicine

Strongyloides stercoralis infection presents with varying degrees of severity, but it often primarily involves the small bowel. In severe infection and cases of hyperinfection, ileus and small-bowel obstruction may prevent enteral absorption of anthelminthics such as ivermectin. At present there are no parenteral anthelminthics licensed for use in humans.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research